ArticleCancer research communications2023

Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients.

Tomoyuki Satake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.